These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7200896)

  • 1. An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancer.
    Child JA; Bono AV; Fossa SD; Ten Bokkel Huinink WW; De Pauw M; Stoter G
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):85-7. PubMed ID: 7200896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP; Richie JP; Gittes RF; Mayer RJ; Skarin AT
    Cancer Treat Rep; 1981; 65(1-2):17-20. PubMed ID: 7226167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
    Fuks JZ; Van Echo DA; Aisner J; Mitchell EP; Woolley PV; Wiernik PH
    Cancer Clin Trials; 1981; 4(4):411-4. PubMed ID: 7318123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of methyl-GAG (NSC-32946) in squamous cell and adenocarcinoma of the lung.
    Samson MK; Baker LH; Cummings G; Talley RW
    Am J Clin Oncol; 1982 Dec; 5(6):631-3. PubMed ID: 7165005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential inhibition of polyamine synthesis. A phase I trial of DFMO (alpha-difluoromethylornithine) and methyl-GAG [methylglyoxal-bis(guanylhydrazone)].
    Warrell RP; Coonley CJ; Burchenal JH
    Cancer Chemother Pharmacol; 1983; 11(2):134-6. PubMed ID: 6414731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of methyl-GAG (methylglyoxal-bis[guanylhydrazone]) in patients with advanced malignant lymphoma.
    Warrell RP; Lee BJ; Kempin SJ; Lacher MJ; Straus DJ; Young CW
    Blood; 1981 Jun; 57(6):1011-4. PubMed ID: 7013854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung.
    Killen JY; Mitchell EP; Hoth DF; Willis LL; Gullo JJ; Smith FP; Schein PS; Woolley PV
    Cancer; 1982 Oct; 50(7):1258-61. PubMed ID: 7104970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialyzability of methyl-GAG.
    Jensen B; Williams RD; Ohnuma T; Roboz J
    Cancer Treat Rep; 1983 Mar; 67(3):283-4. PubMed ID: 6831474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of methyl-GAG in advanced renal cancer.
    Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
    Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
    [No Abstract]   [Full Text] [Related]  

  • 10. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer. A Phase II trial of the Southwest Oncology Group.
    Knight WA; O'Bryan RM; Samal B; Costanzi JJ
    Invest New Drugs; 1984; 2(1):71-3. PubMed ID: 6469501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels and urinary excretion of methyl-GAG following iv infusion in man.
    Marsh KC; Liesmann J; Patton TF; Fabian CJ; Sternson LA
    Cancer Treat Rep; 1981; 65(3-4):253-7. PubMed ID: 7237449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of methyl-glyoxal bis-guanylhydrazone (NSC 3296) in advanced ovarian cancer.
    Vogl SE; Pagano M; Horton J
    Am J Clin Oncol; 1984 Dec; 7(6):733-6. PubMed ID: 6528867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP
    Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
    [No Abstract]   [Full Text] [Related]  

  • 14. Methyl-GAG in patients with malignant neoplasms: a phase I re-evaluation.
    Hart RD; Ohnuma T; Holland JF; Bruckner H
    Cancer Treat Rep; 1982 Jan; 66(1):65-71. PubMed ID: 7053268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylglyoxal-bis(guanylhydrazone) (Methyl-GAG): current status and future prospects.
    Warrell RP; Burchenal JH
    J Clin Oncol; 1983 Jan; 1(1):52-65. PubMed ID: 6230418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trials of methylglyoxal-bis (guanylhydrazone).
    Kelsen DP; Yagoda A; Warrell R; Chapman R; Whittes R; Gralla RJ; Casper E; Young CW
    Am J Clin Oncol; 1982 Apr; 5(2):221-5. PubMed ID: 7046414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group.
    Knight WA; Fabian C; Costanzi JJ; Jones SE; Coltman CA
    Invest New Drugs; 1983; 1(3):235-7. PubMed ID: 6678871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
    Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
    Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An EORTC phase II study of vindesine in advanced prostate cancer.
    Jones WG; Fosså SD; Denis L; Coninx P; Glashan RW; Akdas A; De Pauw M
    Eur J Cancer Clin Oncol; 1983 May; 19(5):583-8. PubMed ID: 6683629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylglyoxal-bis(guanylhydrazone) in hormone-resistant adenocarcinoma of the prostate.
    Scher HI; Yagoda A; Ahmed T; Watson RC
    J Clin Oncol; 1985 Feb; 3(2):224-8. PubMed ID: 3968552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.